Concepts (67)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Carpal Tunnel Syndrome | 1 | 2018 | 13 | 0.640 |
Why?
|
| Ulcer | 1 | 2008 | 27 | 0.320 |
Why?
|
| Dermatologic Agents | 1 | 2008 | 32 | 0.320 |
Why?
|
| Methotrexate | 1 | 2008 | 91 | 0.310 |
Why?
|
| Psoriasis | 1 | 2008 | 46 | 0.310 |
Why?
|
| Aphasia | 1 | 2008 | 119 | 0.280 |
Why?
|
| Acute Kidney Injury | 1 | 2008 | 232 | 0.260 |
Why?
|
| Nerve Growth Factors | 4 | 2009 | 75 | 0.240 |
Why?
|
| Eye Proteins | 4 | 2009 | 160 | 0.220 |
Why?
|
| Serpins | 4 | 2009 | 205 | 0.210 |
Why?
|
| Retinal Vessels | 3 | 2005 | 74 | 0.170 |
Why?
|
| Median Nerve | 1 | 2018 | 5 | 0.160 |
Why?
|
| Injections, Intra-Articular | 1 | 2018 | 15 | 0.160 |
Why?
|
| Endothelial Growth Factors | 3 | 2003 | 25 | 0.160 |
Why?
|
| Lymphokines | 3 | 2003 | 49 | 0.160 |
Why?
|
| Vascular Endothelial Growth Factor A | 6 | 2009 | 219 | 0.120 |
Why?
|
| Capillary Permeability | 2 | 2005 | 69 | 0.120 |
Why?
|
| Plasminogen | 2 | 2005 | 28 | 0.120 |
Why?
|
| Proteins | 3 | 2003 | 474 | 0.090 |
Why?
|
| Vascular Endothelial Growth Factor Receptor-2 | 1 | 2009 | 32 | 0.090 |
Why?
|
| Amyloid Precursor Protein Secretases | 1 | 2009 | 59 | 0.080 |
Why?
|
| Drug Overdose | 1 | 2008 | 67 | 0.080 |
Why?
|
| Angiogenesis Inhibitors | 3 | 2004 | 64 | 0.080 |
Why?
|
| Retinal Pigment Epithelium | 1 | 2009 | 145 | 0.080 |
Why?
|
| Diabetic Retinopathy | 2 | 2005 | 110 | 0.070 |
Why?
|
| Retinal Diseases | 1 | 2005 | 40 | 0.060 |
Why?
|
| Angiostatins | 1 | 2004 | 3 | 0.060 |
Why?
|
| Pterygium | 1 | 2003 | 3 | 0.060 |
Why?
|
| Peptide Fragments | 1 | 2005 | 483 | 0.050 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 1 | 2003 | 146 | 0.050 |
Why?
|
| Protein Biosynthesis | 1 | 2002 | 181 | 0.050 |
Why?
|
| Neovascularization, Pathologic | 1 | 2002 | 183 | 0.050 |
Why?
|
| Signal Transduction | 1 | 2009 | 2689 | 0.040 |
Why?
|
| Humans | 4 | 2018 | 68618 | 0.040 |
Why?
|
| Vascular Endothelial Growth Factors | 3 | 2003 | 30 | 0.040 |
Why?
|
| Down-Regulation | 3 | 2005 | 447 | 0.040 |
Why?
|
| Retina | 3 | 2005 | 252 | 0.040 |
Why?
|
| Rats, Inbred BN | 2 | 2005 | 51 | 0.030 |
Why?
|
| Diabetes Mellitus, Experimental | 2 | 2005 | 195 | 0.030 |
Why?
|
| Rats | 3 | 2005 | 5300 | 0.020 |
Why?
|
| Middle Aged | 1 | 2008 | 21147 | 0.020 |
Why?
|
| Permeability | 1 | 2009 | 131 | 0.020 |
Why?
|
| Macular Degeneration | 1 | 2009 | 75 | 0.020 |
Why?
|
| Animals | 4 | 2009 | 20881 | 0.020 |
Why?
|
| Swine | 1 | 2009 | 672 | 0.020 |
Why?
|
| Female | 1 | 2008 | 38074 | 0.020 |
Why?
|
| Drug Administration Routes | 1 | 2005 | 25 | 0.020 |
Why?
|
| Immunoenzyme Techniques | 1 | 2005 | 196 | 0.020 |
Why?
|
| Animals, Newborn | 1 | 2005 | 396 | 0.010 |
Why?
|
| Cells, Cultured | 1 | 2009 | 2673 | 0.010 |
Why?
|
| Oxygen | 1 | 2005 | 386 | 0.010 |
Why?
|
| Kringles | 1 | 2002 | 3 | 0.010 |
Why?
|
| Retinal Neovascularization | 1 | 2002 | 7 | 0.010 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2002 | 55 | 0.010 |
Why?
|
| Hypoxia-Inducible Factor 1, alpha Subunit | 1 | 2002 | 71 | 0.010 |
Why?
|
| Species Specificity | 1 | 2002 | 303 | 0.010 |
Why?
|
| Disease Susceptibility | 1 | 2002 | 179 | 0.010 |
Why?
|
| Mitogen-Activated Protein Kinases | 1 | 2002 | 250 | 0.010 |
Why?
|
| Ischemia | 1 | 2002 | 229 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2003 | 1174 | 0.010 |
Why?
|
| Up-Regulation | 1 | 2002 | 682 | 0.010 |
Why?
|
| Case-Control Studies | 1 | 2003 | 1553 | 0.010 |
Why?
|
| Phosphorylation | 1 | 2002 | 1200 | 0.010 |
Why?
|
| Disease Models, Animal | 1 | 2005 | 2550 | 0.010 |
Why?
|
| RNA, Messenger | 1 | 2002 | 1664 | 0.010 |
Why?
|
| Transcription Factors | 1 | 2002 | 753 | 0.010 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2002 | 2083 | 0.010 |
Why?
|